Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
With the massive popularity of GLP-1 drugs for diabetes and weight loss, the shortages were almost inevitable as Lilly and Novo struggled to keep up with the immense demand for their blockbuster meds
However, in March 2026 the FDA approved the injectable Wegovy HD, manufactured by Novo Nordisk, that has a 7.2 mg dose three times higher
Diabetic Retinopathy
This is a valid concern, and it is indeed possible that these drugs stay expensive for the next couple years due Eli Lilly and Novo Nordisks duopoly, but I think to underestimate the impact they will have because of any delay is short sighted
US$ 22.78
US$ 28.91
US$ 25.47
US$ 21.38
US$ 23.08
